MedImmune Ventures, Inc. Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MedImmune Ventures, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MedImmune Ventures, Inc.. MedImmune Ventures, Inc. is 10% Owner in CORNERSTONE THERAPEUTICS INC ($CRTX) and 10% Owner in APPLIED GENETIC TECHNOLOGIES CORP ($AGTC) and 10% Owner in INOTEK PHARMACEUTICALS CORP ($ITEK) and 10% Owner in CATABASIS PHARMACEUTICALS INC ($CATB) and 10% Owner in G1 Therapeutics, Inc. ($GTHX).
Latest Insider Trading Transactions of MedImmune Ventures, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGTC, CATB, CRTX, GTHX, RCKT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 2017 | GTHX | G1 Therapeutics, I ... | MedImmune Ventures, Inc. | 10% Owner | Sell | S | 19.75 | 200,000 | 3,950,000 | 2,950,630 | 3.2 M to 3 M (-6.35 %) |
| Dec 05 2017 | GTHX | G1 Therapeutics, I ... | MedImmune Ventures, Inc. | 10% Owner | Sell | S | 19.75 | 133,906 | 2,644,644 | 3,150,630 | 3.3 M to 3.2 M (-4.08 %) |
| Nov 22 2017 | GTHX | G1 Therapeutics, I ... | MedImmune Ventures, Inc. | 10% Owner | Sell | S | 20.01 | 200,000 | 4,002,000 | 3,284,536 | 3.5 M to 3.3 M (-5.74 %) |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 673,128 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 2,412,628 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 7,142,857 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | MedImmune Ventures, Inc. | 10% Owner | Buy | P | 15.00 | 75,000 | 1,125,000 | 3,484,536 | 3.4 M to 3.5 M (+2.20 %) |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 3,409,536 | 0 | 3,409,536 | 0 to 3.4 M |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 4,241,780 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 13,866,666 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | MedImmune Ventures, Inc. | 10% Owner | Buy | P | 12.00 | 223,439 | 2,681,268 | 1,632,652 | 1.4 M to 1.6 M (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 330,098 | 0 | 1,409,213 | 1.1 M to 1.4 M (+30.59 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 1,079,115 | 0 | 1,079,115 | 0 to 1.1 M |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 338,551 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 4,013,692 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | MedImmune Ventures, Inc. | 10% Owner | Buy | P | 6.00 | 416,667 | 2,500,002 | 1,917,906 | 1.5 M to 1.9 M (+27.75 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 57,204 | 0 | 1,501,239 | 1.4 M to 1.5 M (+3.96 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 1,255,123 | 0 | 1,444,035 | 188.9 K to 1.4 M (+664.40 %) |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 4.54 | 11,896 | 54,008 | 11,896 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.13 | 416,361 | 54,002 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 5,699,111 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 11,893,926 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 6,409,436 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 11,478,652 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Buy | P | 12.00 | 75,735 | 908,820 | 1,452,196 | 1.4 M to 1.5 M (+5.50 %) |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 1,376,461 | 0 | 1,376,461 | 0 to 1.4 M |
| Jun 04 2004 | CRTX | CORNERSTONE THERAP ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 10,714,286 | 0 | 0 | |
| Jun 04 2004 | CRTX | CORNERSTONE THERAP ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 2,857,142 | 0 | 2,857,142 | 0 to 2.9 M |
Page: 1